カテゴリー： QYResearch, 世界, 医療/バイオ

ファビピラビル錠のグローバル市場2023年：ブランド薬、ジェネリック薬

◆英語タイトル：Global Favipiravir Tablets Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8760）◆商品コード：QYR23MA8760
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：91
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のファビピラビル錠市場について調査・分析し、世界のファビピラビル錠市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（ブランド薬、ジェネリック薬）、用途別セグメント分析（インフルエンザウイルス、新型コロナウイルス感染症、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、ChemRar Group、Glenmark、Fujifilm、Dr. Reddy、R-Pharma、Cipla、Lupin、Sun Pharma、Hisun Pharmなどが含まれています。世界のファビピラビル錠市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ファビピラビル錠市場規模を推定する際に考慮しました。

・ファビピラビル錠市場の概要
- 製品の定義
- ファビピラビル錠のタイプ別セグメント
- 世界のファビピラビル錠市場規模：タイプ別分析（ブランド薬、ジェネリック薬）
- ファビピラビル錠の用途別セグメント
- 世界のファビピラビル錠市場規模：用途別分析（インフルエンザウイルス、新型コロナウイルス感染症、その他）
- 世界のファビピラビル錠市場規模予測（2018年-2029年）
- ファビピラビル錠の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ファビピラビル錠市場の競争状況およびトレンド

・ファビピラビル錠の地域別市場規模
- 北米のファビピラビル錠市場規模（2018年-2029年）
- アメリカのファビピラビル錠市場規模（2018年-2029年）
- ヨーロッパのファビピラビル錠市場規模（2018年-2029年）
- アジア太平洋のファビピラビル錠市場規模（2018年-2029年）
- 中国のファビピラビル錠市場規模（2018年-2029年）
- 日本のファビピラビル錠市場規模（2018年-2029年）
- 韓国のファビピラビル錠市場規模（2018年-2029年）
- インドのファビピラビル錠市場規模（2018年-2029年）
- オーストラリアのファビピラビル錠市場規模（2018年-2029年）
- 中南米のファビピラビル錠市場規模（2018年-2029年）
- 中東・アフリカのファビピラビル錠市場規模（2018年-2029年）

・タイプ別セグメント：ブランド薬、ジェネリック薬
- 世界のファビピラビル錠のタイプ別販売量（2018年-2023年）
- 世界のファビピラビル錠のタイプ別売上（2018年-2023年）
- 世界のファビピラビル錠のタイプ別価格

・用途別セグメント：インフルエンザウイルス、新型コロナウイルス感染症、その他
- 世界のファビピラビル錠の用途別販売量（2018年-2023年）
- 世界のファビピラビル錠の用途別売上（2018年-2023年）
- 世界のファビピラビル錠の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
ChemRar Group、Glenmark、Fujifilm、Dr. Reddy、R-Pharma、Cipla、Lupin、Sun Pharma、Hisun Pharm

・産業チェーンと販売チャネルの分析
- ファビピラビル錠産業チェーン分析
- ファビピラビル錠の主要原材料
- ファビピラビル錠の販売チャネル
- ファビピラビル錠のディストリビューター
- ファビピラビル錠の主要顧客

・ファビピラビル錠市場ダイナミクス
- ファビピラビル錠の業界動向
- ファビピラビル錠市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Favipiravir Tablets market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Favipiravir Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Favipiravir Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Favipiravir Tablets include ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma, Cipla, Lupin, Sun Pharma and Hisun Pharm, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Favipiravir Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Favipiravir Tablets.
The Favipiravir Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Favipiravir Tablets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Favipiravir Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm
Segment by Type
Brand Drug
Generic Drug
Segment by Application
Influenza Viruses
COVID-19
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Favipiravir Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Favipiravir Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Favipiravir Tablets Market Overview
1.1 Product Overview and Scope of Favipiravir Tablets
1.2 Favipiravir Tablets Segment by Type
1.2.1 Global Favipiravir Tablets Market Value Comparison by Type (2023-2029)
1.2.2 Brand Drug
1.2.3 Generic Drug
1.3 Favipiravir Tablets Segment by Application
1.3.1 Global Favipiravir Tablets Market Value by Application: (2023-2029)
1.3.2 Influenza Viruses
1.3.3 COVID-19
1.3.4 Others
1.4 Global Favipiravir Tablets Market Size Estimates and Forecasts
1.4.1 Global Favipiravir Tablets Revenue 2018-2029
1.4.2 Global Favipiravir Tablets Sales 2018-2029
1.4.3 Global Favipiravir Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Favipiravir Tablets Market Competition by Manufacturers
2.1 Global Favipiravir Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Favipiravir Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Favipiravir Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Favipiravir Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Favipiravir Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Favipiravir Tablets, Product Type & Application
2.7 Favipiravir Tablets Market Competitive Situation and Trends
2.7.1 Favipiravir Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Favipiravir Tablets Players Market Share by Revenue
2.7.3 Global Favipiravir Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Favipiravir Tablets Retrospective Market Scenario by Region
3.1 Global Favipiravir Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Favipiravir Tablets Global Favipiravir Tablets Sales by Region: 2018-2029
3.2.1 Global Favipiravir Tablets Sales by Region: 2018-2023
3.2.2 Global Favipiravir Tablets Sales by Region: 2024-2029
3.3 Global Favipiravir Tablets Global Favipiravir Tablets Revenue by Region: 2018-2029
3.3.1 Global Favipiravir Tablets Revenue by Region: 2018-2023
3.3.2 Global Favipiravir Tablets Revenue by Region: 2024-2029
3.4 North America Favipiravir Tablets Market Facts & Figures by Country
3.4.1 North America Favipiravir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Favipiravir Tablets Sales by Country (2018-2029)
3.4.3 North America Favipiravir Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Favipiravir Tablets Market Facts & Figures by Country
3.5.1 Europe Favipiravir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Favipiravir Tablets Sales by Country (2018-2029)
3.5.3 Europe Favipiravir Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Favipiravir Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Favipiravir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Favipiravir Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Favipiravir Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Favipiravir Tablets Market Facts & Figures by Country
3.7.1 Latin America Favipiravir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Favipiravir Tablets Sales by Country (2018-2029)
3.7.3 Latin America Favipiravir Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Favipiravir Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Favipiravir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Favipiravir Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Favipiravir Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Favipiravir Tablets Sales by Type (2018-2029)
4.1.1 Global Favipiravir Tablets Sales by Type (2018-2023)
4.1.2 Global Favipiravir Tablets Sales by Type (2024-2029)
4.1.3 Global Favipiravir Tablets Sales Market Share by Type (2018-2029)
4.2 Global Favipiravir Tablets Revenue by Type (2018-2029)
4.2.1 Global Favipiravir Tablets Revenue by Type (2018-2023)
4.2.2 Global Favipiravir Tablets Revenue by Type (2024-2029)
4.2.3 Global Favipiravir Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Favipiravir Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Favipiravir Tablets Sales by Application (2018-2029)
5.1.1 Global Favipiravir Tablets Sales by Application (2018-2023)
5.1.2 Global Favipiravir Tablets Sales by Application (2024-2029)
5.1.3 Global Favipiravir Tablets Sales Market Share by Application (2018-2029)
5.2 Global Favipiravir Tablets Revenue by Application (2018-2029)
5.2.1 Global Favipiravir Tablets Revenue by Application (2018-2023)
5.2.2 Global Favipiravir Tablets Revenue by Application (2024-2029)
5.2.3 Global Favipiravir Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Favipiravir Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 ChemRar Group
6.1.1 ChemRar Group Corporation Information
6.1.2 ChemRar Group Description and Business Overview
6.1.3 ChemRar Group Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 ChemRar Group Favipiravir Tablets Product Portfolio
6.1.5 ChemRar Group Recent Developments/Updates
6.2 Glenmark
6.2.1 Glenmark Corporation Information
6.2.2 Glenmark Description and Business Overview
6.2.3 Glenmark Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Glenmark Favipiravir Tablets Product Portfolio
6.2.5 Glenmark Recent Developments/Updates
6.3 Fujifilm
6.3.1 Fujifilm Corporation Information
6.3.2 Fujifilm Description and Business Overview
6.3.3 Fujifilm Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fujifilm Favipiravir Tablets Product Portfolio
6.3.5 Fujifilm Recent Developments/Updates
6.4 Dr. Reddy
6.4.1 Dr. Reddy Corporation Information
6.4.2 Dr. Reddy Description and Business Overview
6.4.3 Dr. Reddy Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dr. Reddy Favipiravir Tablets Product Portfolio
6.4.5 Dr. Reddy Recent Developments/Updates
6.5 R-Pharma
6.5.1 R-Pharma Corporation Information
6.5.2 R-Pharma Description and Business Overview
6.5.3 R-Pharma Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 R-Pharma Favipiravir Tablets Product Portfolio
6.5.5 R-Pharma Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Cipla Favipiravir Tablets Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lupin Favipiravir Tablets Product Portfolio
6.7.5 Lupin Recent Developments/Updates
6.8 Sun Pharma
6.8.1 Sun Pharma Corporation Information
6.8.2 Sun Pharma Description and Business Overview
6.8.3 Sun Pharma Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sun Pharma Favipiravir Tablets Product Portfolio
6.8.5 Sun Pharma Recent Developments/Updates
6.9 Hisun Pharm
6.9.1 Hisun Pharm Corporation Information
6.9.2 Hisun Pharm Description and Business Overview
6.9.3 Hisun Pharm Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Hisun Pharm Favipiravir Tablets Product Portfolio
6.9.5 Hisun Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Favipiravir Tablets Industry Chain Analysis
7.2 Favipiravir Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Favipiravir Tablets Production Mode & Process
7.4 Favipiravir Tablets Sales and Marketing
7.4.1 Favipiravir Tablets Sales Channels
7.4.2 Favipiravir Tablets Distributors
7.5 Favipiravir Tablets Customers
8 Favipiravir Tablets Market Dynamics
8.1 Favipiravir Tablets Industry Trends
8.2 Favipiravir Tablets Market Drivers
8.3 Favipiravir Tablets Market Challenges
8.4 Favipiravir Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ファビピラビル錠のグローバル市場2023年：ブランド薬、ジェネリック薬(Global Favipiravir Tablets Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • グリコピロレート錠のグローバル市場2023年：0.5mg、1mg、2mg
  • 炭酸リチウム医療用錠剤のグローバル市場2023年：徐放錠、普通錠
  • メトトレキサート錠のグローバル市場2023年：2mg、2.5mg、10mg、その他
  • カプトプリル錠のグローバル市場2023年：25mg、12.5mg

    • ◆H&Iグローバルリサーチのお客様（例）◆